Comments
Loading...
ALX Oncology Holdings Earnings Estimates, EPS & Revenue | NASDAQ:ALXO | Benzinga
ALX Oncology Holdings reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS
$-0.477
Quarterly Revenue
$0.00
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Analyze the earnings history of ALX Oncology Holdings using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALXO | ALX Oncology Holdings | -$0.62 | — | -$0.58 | — | $0.00 | — | — | — | 08/07/2025 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.57 | -$0.34 | -$0.48 | -40.29% | $0.00 | — | $0.00 | — | 05/08/2025 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.79 | -$0.39 | -$0.44 | -12.82% | $0.00 | — | $0.00 | — | 03/06/2025 | Get Alert |
| ALXO | ALX Oncology Holdings | -$1.07 | -$0.78 | -$0.45 | 42.31% | $0.00 | — | $0.00 | — | 11/07/2024 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.84 | -$0.77 | -$0.62 | 19.48% | $0.00 | — | $0.00 | — | 08/08/2024 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.58 | -$0.84 | -$0.57 | 32.14% | $0.00 | — | $0.00 | — | 05/09/2024 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.60 | -$0.86 | -$0.79 | 8.14% | $0.00 | — | $0.00 | — | 03/07/2024 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.71 | -$0.87 | -$1.07 | -22.99% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.67 | -$0.88 | -$0.68 | 22.73% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.47 | -$0.80 | -$0.58 | 27.50% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.56 | -$0.89 | -$0.60 | 32.58% | $0.00 | — | $0.00 | — | 03/09/2023 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.61 | -$0.77 | -$0.71 | 7.79% | $0.00 | — | $0.00 | — | 11/08/2022 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.35 | -$0.63 | -$0.67 | -6.35% | $0.00 | — | $0.00 | — | 08/08/2022 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.47 | — | -$0.47 | — | $0.00 | — | $0.00 | — | 05/09/2022 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.50 | -$0.62 | -$0.56 | 9.68% | $0.00 | — | $0.00 | — | 02/28/2022 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.31 | -$0.52 | -$0.61 | -17.31% | $0.00 | — | $0.00 | — | 11/11/2021 | Get Alert |
| ALXO | ALX Oncology Holdings | -$0.22 | -$0.43 | -$0.35 | 18.60% | $527.00K | — | $0.00 | — | 08/12/2021 | Get Alert |
| ALXO | ALX Oncology Holdings | -$2.37 | — | -$0.31 | — | — | — | $0.00 | — | 05/17/2021 | Get Alert |
| ALXO | ALX Oncology Holdings | -$2.83 | — | -$0.43 | — | — | — | $0.00 | — | 03/18/2021 | Get Alert |
| ALXO | ALX Oncology Holdings | — | -$0.36 | -$0.31 | 13.89% | — | $570.00K | $0.00 | -100.00% | 11/12/2020 | Get Alert |
| ALXO | ALX Oncology Holdings | — | -$0.33 | -$0.22 | 33.33% | — | $750.00K | $527.00K | -29.73% | 08/27/2020 | Get Alert |
ALX Oncology Holdings (ALXO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-08 | $-0.48 | $-0.34 | -40.3 % |
| Q4 | 2025-03-06 | $-0.44 | $-0.39 | -12.8 % |
| Q3 | 2024-11-07 | $-0.45 | $-0.78 | 42.3 % |
| Q2 | 2024-08-08 | $-0.62 | $-0.77 | 19.5 % |
ALX Oncology Holdings (ALXO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2020-11-12 | $0 | $570.00K | -100.0 % |
| Q2 | 2020-08-27 | $527.00K | $750.00K | -29.7 % |
FAQ
When is ALX Oncology Holdings (NASDAQ:ALXO) reporting earnings?
ALX Oncology Holdings (ALXO) is scheduled to report earnings on August 7, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
What were the latest earnings per share (EPS) for ALX Oncology Holdings (NASDAQ:ALXO)?
The Actual EPS was $-0.48, which missed the estimate of $-0.34.
What were ALX Oncology Holdings’s (NASDAQ:ALXO) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
